23
Participants
Start Date
January 31, 2007
Primary Completion Date
October 15, 2012
Study Completion Date
November 30, 2012
Ex-vivo expanded effector cells
This trial will test if the combination of infusing ex vivo expanded cytotoxic effector cells with IL-2 and GM-CSF post-transplant will accelerate immune reconstitution, resulting in an effector cell-versus-myeloma effect and, possibly, improved clinical outcomes.
Dartmouth-Hitchcock Medical Center, Lebanon
The Leukemia and Lymphoma Society
OTHER
Dartmouth-Hitchcock Medical Center
OTHER